Literature DB >> 20462778

Alternative pathway or diversion therapy for urea cycle disorders now and in the future.

Stephen Cederbaum1, Cynthia Lemons, Mark L Batshaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20462778     DOI： 10.1016/j.ymgme.2010.04.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN： 1096-7192            Impact factor:   4.797


× No keyword cloud information.
  6 in total

Review 1.  Essential roles of four-carbon backbone chemicals in the control of metabolism.

Authors:  Sabrina Chriett; Luciano Pirola
Journal:  World J Biol Chem       Date:  2015-08-26

Review 2.  Long-Term Follow-Up on a Cohort Temporary Utilization Authorization (ATU) Survey of Patients Treated with Pheburane (Sodium Phenylbutyrate) Taste-Masked Granules.

Authors:  Yves Kibleur; Nathalie Guffon
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

Review 3.  Ammonia toxicity to the brain.

Authors:  Olivier Braissant; Valérie A McLin; Cristina Cudalbu
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

4.  Assessment of quality of life of the children and parents affected by inborn errors of metabolism with restricted diet: preliminary results of a cross-sectional study.

Authors:  Alexandre Fabre; Karine Baumstarck; Aline Cano; Anderson Loundou; Julie Berbis; Brigitte Chabrol; Pascal Auquier
Journal:  Health Qual Life Outcomes       Date:  2013-09-19       Impact factor: 3.186

Review 5.  Profile of sodium phenylbutyrate granules for the treatment of urea-cycle disorders: patient perspectives.

Authors:  Luis Peña-Quintana; Marta Llarena; Desiderio Reyes-Suárez; Luis Aldámiz-Echevarria
Journal:  Patient Prefer Adherence       Date:  2017-09-06       Impact factor: 2.711

6.  Results from a Nationwide Cohort Temporary Utilization Authorization (ATU) survey of patients in france treated with Pheburane(®) (Sodium Phenylbutyrate) taste-masked granules.

Authors:  Yves Kibleur; Dries Dobbelaere; Magalie Barth; Anaïs Brassier; Nathalie Guffon
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.